Interleukin-27 suppresses experimental autoimmune encephalomyelitis during bone marrow stromal cell treatment

J Autoimmun. 2008 Jun;30(4):222-9. doi: 10.1016/j.jaut.2007.10.001. Epub 2007 Nov 8.

Abstract

Interleukin (IL)-17 is a key inflammatory cytokine in autoimmune disease and may play an important role in the development of experimental autoimmune encephalomyelitis (EAE). In this study, we observed decreased IL-17 and increased IL-27 in EAE rats treated with bone marrow stromal cells (BMSCs). Neutralization of IL-27 resulted in recovery of the BMSCs effect. Adoptive transfer induction of EAE was poor by BMSC-stimulated MNCs, but could be induced by MNCs stimulated by BMSCs under blockade of IL-27 signaling. These results demonstrate that BMSCs may suppress the development of EAE, possibly via secretion of IL-27, which can inhibit IL-17 production or Th17 cell generation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow Transplantation*
  • Cytokines / biosynthesis
  • Encephalomyelitis, Autoimmune, Experimental / immunology
  • Encephalomyelitis, Autoimmune, Experimental / metabolism*
  • Encephalomyelitis, Autoimmune, Experimental / prevention & control*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Immunotherapy, Adoptive
  • Interleukin-17 / metabolism*
  • Rats
  • Rats, Inbred Lew
  • Stromal Cells / transplantation*

Substances

  • Cytokines
  • Interleukin-17